An increasing number of b-school graduates are exploring tea-based services and products for businesses and some of them have tasted success too.

His company was 1st Indian supplier of contraceptive devices to the govt

ShopClues does 1.5 million transactions a month and claims to have 40 million monthly visitors.

Zomato is on an acquisition spree, has taken over 5 firms in the past one year.

Jabong has joined hands with 10 boutiques, such as Meo Home Craft (for bags by rural artisans from Tijara, Rajasthan), Rinku Sobti (womenswear), Nidhi Munim, Crazy Palette (clutches & bags) and Uttama Bhatt (ethnic womenswear).

The ban on taxi aggregators can put at risk investments of at least Rs 2,000 crore (Rs 20 billion), made by private equity (PE) and venture capital (VC) investors.

Anupam Mittal, the fund man behind OlaCabs has lined up more investments.

Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations

Each year, at least 10 million Indians marry and the market is estimated at nearly $35 billion, growing at about 25 per cent annually.

On the investor side, we realised most of the funds have foreign capital, thus closing down the opportunity to the Indian investor.

While the two high-profile exits in pharmaceutical and telecom have raised concerns over regulatory hassles in the country, Japanese investors are still keen to tap into India's consumer growth story and many more merger and acquisition deals are in the offing in this space.

Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management of the latter only after its $4-billion acquisition deal is complete.

Private equity players believe it to be lucrative to invest in designer labels.

At present,Satish Khanna he is associated with companies such as Fullife Healthcare, Kagashin, Hi Tech, Provivi, Status Quo and Concord.

PE giants Apollo, Bain Capital and Advent International are keen to pick stake in Viom

For the past few years, Avigo has been in talks with many strategic players, including private equity investors, to sell its stake in Spykar.

According to industry estimates, the sector's revenue would increase eight-10 per cent in 2013-14, against 12 per cent in 2012-13.